Schedule 13G ownership disclosure
MOLECULIN BIOTECH INC
Security class unavailable · CUSIP: 60855D101
Event date: 2020-02-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,750,000
- Percent of class
- 7.0500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-20-000870
- Form type
- SC 13G
- Filer
- Empery Asset Management, LP
- CIK
- CIK 1469336
- Filed
- Feb 11, 2020
- Reporting period
- Feb 06, 2020
- Description
- Schedule 13G beneficial ownership